The Pennsylvania county is funding a study into whether the GLP-1 drug can help people with substance use disorders.
Recap by typeshit. Post by Facebook on Facebook.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
The telehealth company is also adding blood testing services alongside the lower costs for its compounded GLP-1 options.
Huberman says verified, US-made sourcing would change the peptide market, and wonders which compounds beyond GLPs would qualify.
Researchers built a topology-guided add-on to AlphaFold3 aimed at the threaded tail that trips up lasso peptide structure prediction.
Gannan Medical University researchers screened 6,000 candidates from Hypsizygus marmoreus and found peptides that may help cut sodium without losing flavor.
Loading…